ELEPHANTIASIS

Condition: Elephantiasis, or lymphatic filariasis, is a disfiguring condition caused by microscopic, parasitic worms. Currently, there are 120 million people infected, and one-third of those people are seriously incapacitated by it. It is most prevalent in Africa and Southeast Asia, especially in India. It is more common in men than in women, and in endemic communities, up to 50% of men and 10% of women may be affected.
Causes: The parasites are spread from human to human by mosquito bites. It is very common in poor, densely populated areas. Once inside the body, the worms and their offspring clog the lymphatic vessels causing an immune response and extreme swelling in the victim.
Effects: The effects of elephantiasis are extreme. The most visible effect is acute swelling primarily in the lower extremities, especially the legs, feet, and genitals. Swelling can also occur in the torso, arms, breasts, and even the face. In addition to the visible swelling, elephantiasis can damage internal organs as well. In many communities, there is a social stigma against those infected, and they often suffer from psychological and emotional issues.
Treatment: The treatment for elephantiasis is not clearly defined. However, a combination of drugs, which varies depending on the region, along with rigorous cleaning of the affected area has proved effective. Two drug companies, SmithKline Beecham and Merck, have collaborated with the World Health Organization, and have agreed to donate doses of their respective drugs, albendazole and ivermectin, until the disease is eradicated. Several other organizations have also joined the fight, and it is hoped that the disease will be completely eradicated by 2020.
Recent News about Elephantiasis:
New DNA Coding to Track Mosquitoes
Campaign to End Elephantiasis in Fiji Continues

If YOU want to do something about Elephantiasis, YOU can support these organizations:
The Global Alliance to Eliminate Lymphatic Filariasis
The Carter Center